[1]
A. Nikkhah, “Role of Vesicular Monoamine Transporter2 (VMAT2) Inhibitors in Hyperkinetic Movement Disorders - A Brief Review”, Iran J Child Neurol, vol. 15, no. 3, Jul. 2021.